approval
saveTREMFYA (GUSELKUMAB) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025 · 374d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025 · 374d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalJun 17, 2025 · 475d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalMar 25, 2025 · 559d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalMar 20, 2025 · 564d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 11, 2024 · 754d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalJun 29, 2023 · 1194d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalJul 13, 2020 · 2275d ago
same company · ±60 days · 6
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025
- approvalSIMPONI (GOLIMUMAB) — FDA approvalOct 1, 2025
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalOct 2, 2025
- approvalteclistamab: TECVAYLI (TECLISTAMAB-CQYV) — FDA approvalOct 2, 2025
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalSep 3, 2025
comments(0)
5-min edit window · permanent after that